Cleared Special

K043167 - PHAMATECH QUICKSCREEN BENZODIAZEPINES TEST, MODELS 9025, 9026, 9027T, 9153T AND 9195X
(FDA 510(k) Clearance)

Dec 2004
Decision
43d
Days
Class 2
Risk

K043167 is an FDA 510(k) clearance for the PHAMATECH QUICKSCREEN BENZODIAZEPINES TEST, MODELS 9025, 9026, 9027T, 9153T AND 9195X. This device is classified as a Enzyme Immunoassay, Benzodiazepine (Class II - Special Controls, product code JXM).

Submitted by Phamatech, Inc. (San Diego, US). The FDA issued a Cleared decision on December 29, 2004, 43 days after receiving the submission on November 16, 2004.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.3170.

Submission Details

510(k) Number K043167 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 16, 2004
Decision Date December 29, 2004
Days to Decision 43 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JXM — Enzyme Immunoassay, Benzodiazepine
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3170

Similar Devices — JXM Enzyme Immunoassay, Benzodiazepine

All 89
Alinity c Benzodiazepines Reagent Kit
K243498 · Microgenics Corporation · Dec 2024
ONLINE DAT Benzodiazepines II
K221765 · Roche Diagnostics · Dec 2022
CEDIA Benzodiazepine Assay
K190968 · Microgenics Corporation · Dec 2019
DRI Benzodiazepine Assay
K173963 · Microgenics Corporation · Feb 2018
Psychemedics Microplate EIA for Benzodiazepines in Hair
K163590 · Psychemedics Corporation · Sep 2017
Healgen Multi-Drug Urine Test Cup; Healgen Multi-Drug Urine Test Dip Card
K163704 · Healgen Scientific, LLC · Aug 2017